Unité de Fabrication des Médicaments S.A (BVMT:UMED)

Tunisia flag Tunisia · Delayed Price · Currency is TND
9.00
0.00 (0.00%)
At close: Dec 15, 2025
25.00%
Market Cap288.00M
Revenue (ttm)153.79M
Net Income (ttm)22.22M
Shares Out32.00M
EPS (ttm)0.69
PE Ratio12.96
Forward PE12.16
Dividend0.57 (6.33%)
Ex-Dividend DateAug 26, 2025
Volume26,499
Average Volume42,100
Open9.08
Previous Close9.00
Day's Range8.95 - 9.08
52-Week Range6.83 - 9.60
Beta0.03
RSI64.86
Earnings DateDec 5, 2025

About BVMT:UMED

Unité de Fabrication des Médicaments S.A. develops, manufactures, markets, and sells generic and fashioned medicines in Tunisia and internationally. The company offers ophthalmic, ENT, inhalation and infusion solutions, injectable fluids and penicillin, and cephalosporin powders for various therapeutic areas under the UNIMED brand name. It exports its products to Africa, Asia, and Europe. The company was founded in 1989 and is headquartered in Sousse, Tunisia. [Read more]

Industry Pharmaceutical Preparations
Founded 1989
Employees 572
Stock Exchange Tunis Stock Exchange
Ticker Symbol UMED
Full Company Profile

Financial Performance

In 2024, BVMT:UMED's revenue was 147.68 million, an increase of 8.58% compared to the previous year's 136.00 million. Earnings were 19.37 million, an increase of 249.30%.

Financial Statements

News

There is no news available yet.